Abstract | OBJECTIVES:
Anaplastic thyroid carcinomas (ATC) are highly aggressive tumours unresponsive to any available radio- or chemotherapeutic protocol, with a median survival rate of 4-5 months from the time of diagnosis. We previously demonstrated that ATC are characterized by increased expression of the kinases Aurora-A, -B and -C, involved in the regulation of multiple steps of the mitotic phase. In this study, the in vitro effects of SNS-314 mesylate, a pan-inhibitor of the Aurora kinases, on growth and tumorigenicity of ATC cells were evaluated. MATERIALS AND METHODS: The effects of SNS-314 mesylate were assessed on the ATC derived cell lines CAL-62, 8305C, 8505C and BHT-101 by means of cell proliferation assay, immunofluorescence, cytofluorimetry, time lapse microscopy, and colony formation in soft agar. RESULTS: Treatment of the different ATC cells with SNS-314 mesylate inhibited proliferation in a time- and dose-dependent manner, with IC(50) comprised between 2.6 nM and 26.6 nM. CAL-62 cells exposed for 24 h to SNS-314 mesylate 100 nM evidenced a significant augmentation of the apoptotic index. Time-lapse video-microscopy of CAL-62 cells showed that SNS-314 mesylate prevents the completion of mitosis leading to polyploidy. Western blot experiments demonstrated that the auto-phosphorylation of the Aurora kinases as well as histone H3 phosphorylation in CAL-62 treated cells was inhibited. Finally, the drug inhibited colony formation in soft agar of all cell lines. CONCLUSIONS: Our results demonstrated that SNS-314 mesylate is capable to efficiently reduce cell growth and tumorigenicity of different ATC derived cell lines suggesting its potential therapeutic value for ATC treatment.
|
Authors | E Baldini, S Sorrenti, E D'Armiento, E Guaitoli, S Morrone, V D'Andrea, L Gnessi, C Moretti, A Antonelli, A Catania, E De Antoni, S Ulisse |
Journal | La Clinica terapeutica
(Clin Ter)
Vol. 163
Issue 5
Pg. e307-13
( 2012)
ISSN: 1972-6007 [Electronic] Italy |
PMID | 23099978
(Publication Type: Journal Article)
|
Chemical References |
- Mesylates
- Phenylurea Compounds
- SNS 314
- Thiazoles
|
Topics |
- Apoptosis
(drug effects)
- Cell Cycle
(drug effects)
- Cell Proliferation
(drug effects)
- Humans
- Mesylates
- Phenylurea Compounds
(pharmacology)
- Thiazoles
(pharmacology)
- Thyroid Carcinoma, Anaplastic
- Thyroid Neoplasms
(pathology)
- Tumor Cells, Cultured
(drug effects)
|